Vimarsana
Biggest News Aggregation in the World

Better Bite Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Better Bite Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Better Bite Ventures Today - Breaking & Trending Today

Deals in brief: Ai Palette, Rukita, and Thryve.Earth secure funding, Sunday and Carro complete acquisitions, nine China deals, and more - Vimarsana News

Deals in brief: Ai Palette, Rukita, and Thryve.Earth secure funding, Sunday and Carro complete acquisitions, nine China deals, and more

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

70/30 Food Tech Nabs $700K to Launch Mycelium Research Lab - Vimarsana News

70/30 Food Tech Nabs $700K to Launch Mycelium Research Lab

70/30 Food Tech has closed a $700,000 seed extension to launch an R&D lab for mycelium protein products, starting with shredded chicken.

70/30 Food Tech Launches Mycelium Research Lab and Successfully Closes Seed Extension - Vimarsana News

70/30 Food Tech Launches Mycelium Research Lab and Successfully Closes Seed Extension

70/30 Food Tech, a Singaporean holding company with operations in China and other parts of Asia, is actively developing low-cost whole-cut mycelium-based protein solutions. These innovative products are positioned as affordable and high-quality alternatives to traditional animal-based proteins, tailored for the Asian market.

Source: yahoo.com
Miruku Raises $5M in Pre-Series A for Molecular-Farmed Dairy - Vimarsana News

Miruku Raises $5M in Pre-Series A for Molecular-Farmed Dairy

New Zealand's Miruku has raised $5M in pre-Series A investment to expand its molecular farming platform for dairy proteins and fats.

UMAMI Bioworks: 'Startups cannot be in the capex business' - Vimarsana News

UMAMI Bioworks: 'Startups cannot be in the capex business'

Who is going to fund cultivated meat facilities if VC funds are no longer willing to stump up cash for capex projects, asks UMAMI Bioworks